Koschinsky ML - Search Results

1

Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.

Becker L, Cook PM, Koschinsky ML. Becker L, et al. Among authors: koschinsky ml. Biochemistry. 2004 Aug 10;43(31):9978-88. doi: 10.1021/bi049536d. Biochemistry. 2004. PMID: 15287725

2

Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.

Rouy D, Koschinsky ML, Fleury V, Chapman J, Anglés-Cano E. Rouy D, et al. Among authors: koschinsky ml. Biochemistry. 1992 Jul 14;31(27):6333-9. doi: 10.1021/bi00142a024. Biochemistry. 1992. PMID: 1627572

3

Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells.

Koschinsky ML, Tomlinson JE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM. Koschinsky ML, et al. Biochemistry. 1991 May 21;30(20):5044-51. doi: 10.1021/bi00234a029. Biochemistry. 1991. PMID: 2036372

4

Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA.

Koschinsky ML, Beisiegel U, Henne-Bruns D, Eaton DL, Lawn RM. Koschinsky ML, et al. Biochemistry. 1990 Jan 23;29(3):640-4. doi: 10.1021/bi00455a007. Biochemistry. 1990. PMID: 2140053

5

Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation.

Sangrar W, Bajzar L, Nesheim ME, Koschinsky ML. Sangrar W, et al. Among authors: koschinsky ml. Biochemistry. 1995 Apr 18;34(15):5151-7. doi: 10.1021/bi00015a028. Biochemistry. 1995. PMID: 7711034

6

Binding of recombinant apolipoprotein(a) to extracellular matrix proteins.

van der Hoek YY, Sangrar W, Côté GP, Kastelein JJ, Koschinsky ML. van der Hoek YY, et al. Among authors: koschinsky ml. Arterioscler Thromb. 1994 Nov;14(11):1792-8. doi: 10.1161/01.atv.14.11.1792. Arterioscler Thromb. 1994. PMID: 7947605

7

Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation.

Gabel B, Yao Z, McLeod RS, Young SG, Koschinsky ML. Gabel B, et al. Among authors: koschinsky ml. FEBS Lett. 1994 Aug 15;350(1):77-81. doi: 10.1016/0014-5793(94)00737-3. FEBS Lett. 1994. PMID: 8062928 Free article.

8

Analysis of structure--function relationships in human apolipoprotein(a).

van der Hoek YY, Kastelein JJ, Koschinsky ML. van der Hoek YY, et al. Among authors: koschinsky ml. Can J Physiol Pharmacol. 1994 Mar;72(3):304-10. doi: 10.1139/y94-046. Can J Physiol Pharmacol. 1994. PMID: 8069777

9

Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells.

Sangrar W, Marcovina SM, Koschinsky ML. Sangrar W, et al. Among authors: koschinsky ml. Protein Eng. 1994 May;7(5):723-31. doi: 10.1093/protein/7.5.723. Protein Eng. 1994. PMID: 8073042

10

Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.

Koschinsky ML, Côté GP, Gabel B, van der Hoek YY. Koschinsky ML, et al. J Biol Chem. 1993 Sep 15;268(26):19819-25. J Biol Chem. 1993. PMID: 8366120 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters